P S Analytical Research Limited 30/06/2023 iXBRL

P S Analytical Research Limited 30/06/2023 iXBRL


2 30/06/2023 2023-06-30 false false false false false false false true false false true false false false false false false false 2022-07-01 Sage Accounts Production 23.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 04513936 2022-07-01 2023-06-30 04513936 2023-06-30 04513936 2022-06-30 04513936 2021-07-01 2022-06-30 04513936 2022-06-30 04513936 2021-06-30 04513936 bus:Director1 2022-07-01 2023-06-30 04513936 core:WithinOneYear 2023-06-30 04513936 core:WithinOneYear 2022-06-30 04513936 core:ShareCapital 2023-06-30 04513936 core:ShareCapital 2022-06-30 04513936 core:RetainedEarningsAccumulatedLosses 2023-06-30 04513936 core:RetainedEarningsAccumulatedLosses 2022-06-30 04513936 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 04513936 core:Non-currentFinancialInstruments 2023-06-30 04513936 core:Non-currentFinancialInstruments 2022-06-30 04513936 bus:SmallEntities 2022-07-01 2023-06-30 04513936 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 04513936 bus:FullAccounts 2022-07-01 2023-06-30 04513936 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 04513936 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30
Company registration number: 04513936
P S Analytical Research Limited
Unaudited filleted financial statements
30 June 2023
P S Analytical Research Limited
Contents
Statement of financial position
Notes to the financial statements
P S Analytical Research Limited
Statement of financial position
30 June 2023
2023 2022
Note £ £ £ £
Fixed assets
Investments 5 65,606 65,606
_______ _______
65,606 65,606
Current assets
Cash at bank and in hand 45,035 195,179
_______ _______
45,035 195,179
Creditors: amounts falling due
within one year 6 ( 25,569) ( 181,319)
_______ _______
Net current assets 19,466 13,860
_______ _______
Total assets less current liabilities 85,072 79,466
_______ _______
Net assets 85,072 79,466
_______ _______
Capital and reserves
Called up share capital 65,000 65,000
Profit and loss account 20,072 14,466
_______ _______
Shareholders funds 85,072 79,466
_______ _______
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 22 March 2024 , and are signed on behalf of the board by:
Paul M Stockwell
Director
Company registration number: 04513936
P S Analytical Research Limited
Notes to the financial statements
Year ended 30 June 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Arthur House, Crayfield Industrial Estate, Main Road, St Paul's Cray, Orpington, Kent, BR5 3HP.The principal activity of the company is that of holding company.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'and the Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
In accordance with their responsibilities as directors, the directors have considered the appropriateness of the going concern basis for the preparation of the financial statements.The directors consider the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Income
Income represents dividends received from fixed asset investments.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1 July 2022 and 30 June 2023 65,606 65,606
_______ _______
Impairment
At 1 July 2022 and 30 June 2023 - -
_______ _______
Carrying amount
At 30 June 2023 65,606 65,606
_______ _______
At 30 June 2022 65,606 65,606
_______ _______
6. Creditors: amounts falling due within one year
2023 2022
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest 14,250 170,000
Other creditors 11,319 11,319
_______ _______
25,569 181,319
_______ _______